The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1365
ISSUE 1365
May 30, 2011
Issue 1365
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
In Brief: Fexofenadine (Allegra) and Fruit Juice
May 30, 2011 (Issue: 1365)
Fexofenadine (Allegra, and others) is the most recent second-generation H1-antihistamine to become available over the counter (OTC). Cetirizine (Zyrtec, and others) and loratadine (Claritin, and others) are already available OTC. Cetirizine can be...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.